Alexander Lankowski 1, Cedric Bien 1,2, Richard Silvera 1,2, Viraj Patel 1, Uriel Felsen 3, Oni Blackstock 1

Similar documents
Does the Addition of HCV Testing to a Rapid HIV Testing Program Impact HIV Test Acceptance? A Randomized Controlled Trial.

STIs in the Indian Country

Behind the Cascade: Analyzing Spatial Patterns Along the HIV Care Continuum

PrEP: Pre-Exposure Prophylaxis to Prevention HIV Infection

PrEP Home Checklist v1.0

REVIEW OF PREP GUIDELINES: A PRIMER FOR THE PRIMARY CARE PRACTITIONER ANTONIO E. URBINA, MD. PrEP Webinar Series

NYC s PrEP Network. Julie Myers, MD, MPH New York City Department of Health and Mental Hygiene

Uptake of Pre-exposure Prophylaxis (PrEP) in Young Men Who Have Sex with Men is Associated with Race, Sexual Risk Behavior and Network Size

Bruce D. Agins, MD MPH Medical Director, AIDS Institute Adherence 2017; Miami

Relationships of HIV- and Race-Based Discrimination to Antiretroviral Treatment Use and Retention in Care among African Americans with HIV

Initiation and engagement in addiction treatment integrated into primary care: the role of gender

Amanda D. Castel, MD, MPH Assistant Professor George Washington University School of Public Health and Health Services

Substance Abuse Services. AIDS Drug Assistance. Oral Health Care. Program (ADAP) Medical Care

Enhancing PrEP Access for Black and Latino Men Who Have Sex with Men

PrEP and Behavioral Strategies for HIV Prevention. Douglas Krakower, MD January 30, 2014

PrEP Implementation in San Francisco. Michael Barajas- Citywide PrEP Navigator San Francisco City Clinic San Francisco Department of Public Health

NYS PrEP Programming. Lyn Stevens, NP, MS, ACRN Office of the Medical Director, AIDS Institute PrEP Monitoring in NYC and NYS February 19, 2016

HIV Prevention Pearls

Buprenorphine Treatment at 11 Years: Trends in an Urban Community Health Center. Tiffany Lu, MD AMERSA Conference Washington DC November 4, 2017

HIV EPIDEMIOLOGY IN NEW YORK CITY

Ryan White Program Demographic Data Fiscal Year 25

Missouri St. Louis TGA 2016 HIV Epidemiological Profile

American Men s Internet Survey (AMIS)

Viral Load Suppression/Any HIV Care 84%

Project Control. An innovative multimedia HIV testing system adapted for teens

TABLE 1. Percentage of respondents to a national survey of young adults, by selected characteristics, according to gender, United States, 2009

New England healthcare providers perceptions, knowledge and practices regarding the use of antiretrovirals for prevention

Fast-Track Your PrEP Knowledge. Jonathan Fritz PrEP Coordinator MDHHS Division of HIV and STD Programs

Characteristics of individuals who are HIV-positive, out of HIV care, and newly diagnosed with Sexually Transmitted Infections

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

HIV Pre- Exposure Prophylaxis

PREVENTION OF HIV IN THE TIMES OF PREP. Daniela Chiriboga, MD Florida Department of Health in Polk County

Disparities in HIV Care. Slides prepared by Kirk Fergus, Intern National Quality Center

The Door is Open PrEP in Practice. Antonio E. Urbina, MD Associate Professor of Medicine Icahn School of Medicine Mount Sinai Hospital

State of Alabama HIV Surveillance 2014 Annual Report

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

2016 Houston HIV Care Services Needs Assessment: Profile of African American Men Who Have Sex with Men (MSM)

PrEP MEASUREMENT IN NYC

PrEP for HIV Prevention. Adult Clinical Guideline from the New York State Department of Health AIDS Institute

HIV Pre-Exposure Prophylaxis Panel

Disclosure. Learning Objectives. Epidemiology. Transmission. Risk of Transmission PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV PREVENTION 50,000.

PEP and PREP. Dr David Hawkins Chelsea and Westminster Hospital

Non-Occupational Post-Exposure HIV Prophylaxis npep

Attendees will be able to:

PrEP 201: Beyond the Basics

Ryan White Part A Overview Kimberlin Dennis Melissa Rodrigo March 21, 2018

Survival among Native American Adolescent and Young Adult Cancer Patients in California

Pre-Exposure Prophylaxis (PrEP) and the Governor s Plan to End AIDS: What Every Clinician Needs to Know

Florida s HIV Testing Efforts

Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation,

Incidence des IST chez les PrEPeurs

-decreased bone Adherence iprex study. -protective effect

Christopher Okunseri, BDS, MSc, MLS, DDPHRCSE, FFDRCSI, Elaye Okunseri, MBA, MSHR, Thorpe JM, PhD., Xiang Qun, MS.

Patterns and predictors of dual contraceptive use among sexually active treatment experienced women living with HIV in British Columbia, Canada.

HIV Interventions along the US-Mexico Border: The Southern California Border HIV/AIDS Project

GAY MEN/MSM AND STD S IN NJ: TAKE BETTER CARE OF YOUR PATIENTS! STEVEN DUNAGAN SPECIAL PROJECTS COORDINATOR NJ DOH STD PROGRAM SEPTEMBER 27, 2016

2016 Houston HIV Care Services Needs Assessment: Profile of the Recently Released

BALTIMORE COUNTY HIV/AIDS EPIDEMIOLOGICAL PROFILE Fourth Quarter Data reported throuh December 31, 2007

ONLINE SUPPLEMENTARY MATERIAL

International Network on Hepatitis in Substance Users

Financial Incentives, Linkage to Care and Viral Suppression HPTN 065 (TLC-Plus) Study. Wafaa El-Sadr ICAP at Columbia University New York, NY

Pre-Exposure Prophylaxis (PrEP) for HIV Infection

Visibility, Attitudes and Opinions of the PrEP Campaign in NYC

State of Alabama AIDS Drug Assistance Program (ADAP) Quarterly Report

Racial and Socioeconomic Disparities in Appendicitis

Bassett Medical Center PPS Community Profile

Acceptability of Anal Cancer Screening Tests Among Gay and Bisexual Men. Joshua Thompson

Pre exposure Prophylaxis (PrEP): Stepping Up HIV Prevention

PHSKC HIV Testing Survey: Knowledge, Attitudes and Practices

Assessing Clinic-Level Factors that Impact Viral Load Suppression

Leveraging Unique Data Sources to Improve Prevention:

THE AFFORDABLE CARE ACT AND HIV MAXIMIZING OPPORTUNITIES FOR COVERAGE AND CARE

Epidemiology of HIV Among Women in Florida, Reported through 2014

Gender differences in sexual behaviors, sexual partnerships, and HIV among drug users in New York City

NJ s Transitional Housing Initiative

HIV/AIDS Bureau Update

Population-specific Challenges Contributing to Disparities in Delivery of Care

Roy M. Gulick, MD, MPH Chief, Division of Infectious Diseases Professor of Medicine Weill Medical College of Cornell University New York City

Pre-Exposure Prophylaxis (PrEP): Best Practices for Pharmacists

San Francisco Medical Monitoring Project (MMP) Maree Kay Parisi Applied Research, Community Health Epidemiology and Surveillance

State of Alabama HIV Surveillance 2013 Annual Report Finalized

PrEP Basics: A Patient-Centered Approach to Providing PrEP

Health Resources and Services Administration and HIV/AIDS Bureau Update

Background: Kirketon Road Centre

Gender Disparities in Viral Suppression and Antiretroviral Therapy Use by Racial and Ethnic Group Medical Monitoring Project,

HIV Prevention Service Provider Survey 2014

HIV Pre-Exposure Prophylaxis (PrEP)

Co-Variation in Sexual and Non-Sexual Risk Behaviors Over Time Among U.S. High School Students:

The role of Integrase Inhibitors during HIV prevention

HIV Continuum of Care Connecticut, 2015

Data to Care: Improving Health Across the HIV Care Continuum in Colorado

Development of an HIV Risk Reduction Intervention for Older Seropositive African American Men

Pre-exposure Prophylaxis for HIV Prevention

Dr Michelle Hanlon Consultant physician, Genitourinary Medicine. Olafiaklinikken, Oslo University Hospital. National Advisory Unit for STIs

PrEP Active Referrals at the Chicago Dept. of Public Health: past, present, and future. Ramona Bhatia, MD MS Supervising Physician HIV/STI 9/29/16

Apurba Chakraborty MBBS, MPH Dima M. Qato PharmD, MPH, PhD Professor Mark S. Dworkin MD, MPHTM The University of Illinois at Chicago

BIOGRAPHICAL SKETCH. NAME: Chinazo O. Cunningham, MD, MS. era COMMONS USER NAME (credential, e.g., agency login): CHINAZO1

GETTING TO ZERO AND ENDING THE EPIDEMIC

Non-medical use of prescription drugs and sexual risk behaviors among depressed adolescents

ACRONYMS AND KEYWORDS

Transcription:

Alexander Lankowski 1, Cedric Bien 1,2, Richard Silvera 1,2, Viraj Patel 1, Uriel Felsen 3, Oni Blackstock 1 1 Division of General Internal Medicine, Montefiore Health System & Albert Einstein College of Medicine, Bronx, NY, USA 2 Department of Family and Social Medicine, Montefiore Medical Center, Bronx, NY, USA 3 Division of Infectious Diseases, Albert Einstein College of Medicine, Bronx, NY, USA

Background Optimal PrEP adherence requires retention in care Initial PrEP Visit + Prescription Prescription + Clinic Visit Prescription + Clinic Visit 1 to 3 months 3 months every 3 months Outside of specialized HIV prevention programs, there is a paucity of data on factors that predict retention in PrEP care

Research Objective To determine the patient and health system factors associated with retention in care among PrEP users in a large, integrated, urban health system

HIV Incidence NYC 2014

Study Population Inclusion criteria: HIV-negative individuals >18 years old Prescribed TDF/FTC during 2011-2015 Exclusion criteria: Chronic active hepatitis B infection TDF/FTC exclusively for PEP

Study Design Retrospective cohort analysis Manual chart review performed to obtain: Baseline characteristics at time of initial PrEP prescription Social / Demographic e.g. gender, race, ethnicity, insurance status Sexual / Behavioral e.g. sexual orientation, HIV-related risk behaviors Provider / Health System e.g. clinic setting, provider training level Longitudinal follow-up data (through August 1, 2016) TDF/FTC Prescription Renewals/Refills Clinical Encounter Data e.g. office visits, phone / web encounters

Outcome of Interest 6-month retention in PrEP care defined as having a PrEP prescription at 180 (+/- 60) days after PrEP start date

Statistical Analysis Bivariate logistic regression analysis done initially to identify variables associated with our outcome of interest Multivariable logistic regression model, adjusting for covariables significant (p<0.05) in bivariate analysis

Baseline Characteristics: Demographic Variable N=107 Age in years, median (range) 28 (19 63) Gender n (%) Female 30 (28.0%) Male 74 (69.2%) Transgender (M!F) 3 (2.8%) Race / Ethnicity n (%) Hispanic 38 (35.5%) Non-Hispanic Black 28 (26.2%) Other / Not Reported 31 (38.3%) Insurance n (%) Private 40 (37.4%) Public (Medicare or Medicaid) 62 (58.0%) Uninsured 5 (4.7%)

Baseline Characteristics: Sexual / Behavioral WSW 1% Sexual Orientation Bisexual 7% Unknown 4% HIV Risk Behaviors n (%) Sex with known HIV+ Partner 58 (54.2%) Condomless Intercourse 52 (48.6%) MSM 52% Heterosexual 36% Female 72% Male 28% Multiple Current or Anonymous Sex Partners 38 (35.5%) Transactional Sex 4 (3.7%) History of IVDU 4 (3.7%) Prior npep 14 (13.1%)

Baseline Characteristics: Provider / Health System Variable n (%) Clinic Setting Primary Care (Internal Medicine or Family Medicine) 56 (52.3%) Sexual Health Center 22 (20.6%) Infectious Diseases (Adult or Pediatric) 17 (15.9%) Adolescent Medicine 6 (5.6%) OB/GYN 5 (4.7%) Provider Type Attending Physician 76 (71.3%) Trainee (Resident or Fellow) 19 (17.7%) Nurse Practitioner 12 (11.2%)

Results Overall Retention 6-Month Retention in PrEP Care 58% 42% Retained Not Retained

Results: Bivariate Analysis of Variable Factors Associated with 6-Month Retention Unadjusted Odds Ratio (95% CI) Age >25 (vs. age 25) 0.84 (0.36 1.94) Female gender (vs. non-female) 0.49 (0.20 1.20) Hispanic (vs. all other) 1.26 (0.34 4.68) Non-Hispanic Black (vs. all other) 0.47 (0.11 1.95) Heterosexual (vs. not heterosexual) 0.20 (0.08 0.50) Any Sexual Partner HIV+ (vs. no documentation of HIV+ partner) 0.51 (0.23 1.10) Main Sexual Partner HIV+ (vs. main partner not documented as HIV+) 0.38 (0.17 0.86) Multiple Partners (vs. no documentation of multiple current partners) 2.32 (1.03 5.20) Condomless Sex (vs. no documentation of condomless sex) 0.88 (0.41 1.89) Prior npep (vs. no prior npep) 2.85 (0.88 9.18) PrEP from Primary Care (vs. PrEP from any other setting) 0.92 (0.43 1.98) PrEP Prescribed by Attending (vs. any other level provider) 5.78 (2.01 16.6) Private Insurance (vs. any other insurance status) 1.98 (0.89 4.39)

Results: Multivariable Analysis of Factors Associated with 6-Month Retention Variable Adjusted* Odds Ratio (95% CI) Heterosexual (vs. all other sexual orientations) 0.23 (0.07 0.72) PrEP Prescribed by Attending Physician (vs. any other level provider) 6.38 (2.08 19.6) * Adjusted for the following covariables that were significant (p < 0.05) in bivariate analysis: sexual orientation, main partner HIV+, multiple sexual partners, provider type

Limitations Retrospective analysis with reliance on chart review for data collection Variable detail in documentation of sexual / behavioral risk factors in provider notes PrEP prescription is only a proxy for retention Prescription duration and timing likely to vary among PrEP providers

Summary of Key Findings Individuals who were documented as heterosexual were significantly less likely (aor 0.23) to be retained in PrEP care at 6 months Individuals prescribed PrEP by an attending physician were significantly more likely (aor 6.38) to be retained in PrEP care at 6 months

Future Directions Why might retention be lower among heterosexuals in this cohort? Why might retention be higher when PrEP prescribed by an attending physician? Need for larger prospective studies to better evaluate factors that impede or facilitate long-term engagement in PrEP care

Acknowledgements Mentorship: Oni Blackstock Sachin Jain Montefiore / Einstein Internal Medicine Residency Program Division of General Internal Medicine, Montefiore Medical Center Division of Infectious Diseases, Montefiore Medical Center Department of Family and Social Medicine, Montefiore Medical Center The Montefiore Oval Center